酸感应离子通道-1A (ASIC1A) 对可卡因诱导的突触适应的影响
Subhash C Gupta1,2, Rebecca J Taugher-Hebl1,2, Jason B Hardie1,2
1Department of Psychiatry, University of Iowa, Iowa City, IA, United States.
Frontiers in physiology
|June 30, 2023
概括
酸感应离子通道 (ASIC) 和它们的ASIC1A子单元在药物滥用中至关重要. 在小鼠中破坏ASIC1A模仿戒断,但可卡因使这些效应正常化,表明治疗潜力.
科学领域:
- 神经科学是一个神经科学.
- 分子生物学分子生物学
- 药理学 药理学是指药理学的学科.
背景情况:
- 慢性药物滥用会改变核心中枢中状神经元 (MSN) 的突触功能,导致渴望和复发.
- 酸感应离子通道 (ASIC),特别是ASIC1A,与这些药物诱导的突触修饰有关.
研究的目的:
- 研究可卡因暴露对ASIC1A缺陷小鼠突触可塑性的时间影响.
- 为了确定ASIC1A在调解这些突触变化的作用的细胞部位.
- 探索蛋白质合成在ASIC1A依赖的突触适应中的作用.
主要方法:
- 使用了ASIC1A淘汰赛小鼠 (Asic1a-/-) 和野生类型的 littermates.
- 在不同时间点服用可卡因和评估突触功能 (AMPAR/NMDAR比率,AMPAR纠正,树突脊柱密度).
- 在特定的MSN亚群中基因破坏ASIC1A,并检查了细胞自主效应.
- 研究了蛋白质合成抑制剂阿尼索米的影响.
主要成果:
- 在未使用毒品的小鼠中,ASIC1A的破坏诱导了类似于野生类型可卡因戒断的突触变化.
- 在Asic1a-/-小鼠中,可卡因暴露导致AMPAR/NMDAR比率,整形和脊柱密度的时间依赖正常化.
- ASIC1A的作用是细胞自主性的,主要影响多巴胺受体1-表达MSN.
- 抑制蛋白质合成在Asic1a-/-小鼠中使突触变化正常化.
结论:
- ASIC1A在调解与慢性药物暴露相关的突触适应方面发挥着关键作用.
- 这些发现突出了ASIC1A作为缓解药物诱导的突触变化和行为的潜在治疗点.
- 细胞作用部位和蛋白质合成的参与为ASIC1A的作用提供了机理性的见解.
相关概念视频
Ligand-Gated Ion Channel Receptor: Gating Mechanism
2.3K
Ligand-gated ion channels are transmembrane proteins that play a vital role in intercellular communication and functions of the nervous system. They allow the influx of ions across the membrane once the neurotransmitter binds, allowing the subsequent transmission of electrical excitation across the neurons. Other ligand-gated ion channels, like the γ-aminobutyric acid (GABA) receptor, permit anions like chloride into the cells on the binding of the GABA molecule. Their entry into the cell...
2.3K
CNS Stimulants: Cocaine, Amphetamines and Cannabinoids
265
CNS stimulants, such as cocaine, amphetamines, and cannabinoids, have varying structures and mechanisms of action that lead to different therapeutic effects and side effects. Cocaine, with its molecular formula C17H21NO4, is a tropane alkaloid and a tertiary amino compound. It has two chemical forms: the hydrochloride salt and the "freebase." The former is in powder form, while the latter involves removing the hydrochloride salt to create a form that can be smoked. Cocaine exerts its...
265
Neurochemical Transmission: Sites of Drug Action
2.5K
Neurochemical transmission, the conduction of electrical impulses between neurons mediated by neurotransmitters, plays a vital role in various physiological processes. Autonomic drugs exert their effects by modulating neurotransmission within the autonomic nervous system. For instance, drugs such as hemicholinium block the precursor uptake necessary for synthesizing acetylcholine, an essential autonomic neurotransmitter. Following synthesis, neurotransmitters are stored in vesicles. Metyrosine...
2.5K
Drugs Affecting Neurotransmitter Release or Uptake
1.1K
Certain drugs can affect how neurotransmitters called catecholamines, are released or taken back up in the adrenergic neuron. They can have different effects on the body's sympathetic transmission. Reserpine, a natural compound found in the Rauwolfia shrub, blocks a transporter called vesicular monoamine transporter (VMAT), which leads to a buildup of catecholamines in the cell and reduces sympathetic transmission. Another drug called guanethidine works in multiple ways, including blocking...
1.1K
Antiepileptic Drugs: Modulators of Neurotransmitter Release Mediated by SV2A Protein
350
Antiepileptic drugs, such as levetiracetam (Keppra) and brivaracetam (Briviact), have emerged as crucial tools in managing epilepsy. These medications exert their therapeutic effects by targeting the synaptic vesicle protein SV2A, a transmembrane glycoprotein primarily found in the brain.
SV2A is a transmembrane glycoprotein located predominantly in the brain, modulating the release of neurotransmitters for neuronal communication. Both levetiracetam and brivaracetam exhibit a high affinity for...
SV2A is a transmembrane glycoprotein located predominantly in the brain, modulating the release of neurotransmitters for neuronal communication. Both levetiracetam and brivaracetam exhibit a high affinity for...
350


